The Pulmonary Vascular Research Institute

Pulmonary Vascular Research Institute (PVRI) is a global medical organisation focused on the improvement of care and awareness of pulmonary vascular diseases.

[The Pulmonary Vascular Research Institute @PVRI]

Happening tomorrow ⏰

Blood Biomarkers in Pulmonary Arterial Hypertension – New Insights
📅 12 November 2026
🕓️ 16:00 - 17:00 GMT

Join experts from across the PH community as they discuss emerging biomarkers, methodological challenges, risk stratification and new approaches to predicting outcomes in PAH.

➡️ Register now: https://t.co/UJFgIVd6Gj

[The Pulmonary Vascular Research Institute @PVRI]

🌍 New for #PVRI2027: Bayer is supporting new travel awards, offering a total of £10,000 (up to a max of £1,700 per person) to help more early-career delegates from across the world join us in Bangkok & applications are OPEN now.

These awards are in addition to PVRI’s previous round of travel awards.

Application deadline: 25 November 2026, 09:00 GMT
Applicants notified: 27 November 2026

Find out more & apply: https://t.co/BwgjLarOWu

[The Pulmonary Vascular Research Institute @PVRI]

One week to go! 📣

Join Jessica Badlam for the first Women's Health Career Pathways webinar.

Women's Health Career Pathways: Jessica Badlam
📅 19 November 2026
🕓️ 16:00 GMT

Hear her personal career journey and gain practical advice on mentorship, collaboration, leadership, and building a career in women's health and PH research.

➡️ Register: https://t.co/1lM5FNoRjR

[The Pulmonary Vascular Research Institute @PVRI]

New research in Pulmonary Circulation 🫁

Effect of Incident Pulmonary Arterial Hypertension on Risk of Newly-Diagnosed Mental Health Conditions
📆 07 September 2026
🔢 16(3), e70398
👤 Anna Watzker, Oscar Patterson-Lomba, Cameron Fowler, Yan Song, Alejandro Victores, Alen Dezia, Jiayang Li, Azeem Banatwala, Qingyi Cai, Lana Melendres-Groves

➡️ Read the full research article: https://t.co/rJ1Ln9s0ya

[The Pulmonary Vascular Research Institute @PVRI]

Speaker spotlight💡

PVRI 2027 Bangkok will explore some of the biggest clinical and scientific challenges facing the PH community today, from critical care and Group 2 PH to advanced imaging and right ventricular recovery.

Here’s a glimpse of what’s to come ⬇️

Preoperative Risk Assessment in PH: Assessing Hemodynamics, RV Function, & Surgical Risk
🎙 Monica Mukherjee, Johns Hopkins University

Novel Diagnostics for the Next Generation of Therapeutics
🎙 Bruno Thal, Justus Liebig University of Giessen

Multimodal AI Pipelines for PAH Detection: Bridging ECG, Chest Imaging and Clinical Translation
🎙 Wen-Hui Fang, Tri-Service General Hospital / National Defense Medical Center

The Distinct Pulmonary Vascular Phenotype of Group 3 PH
🎙 Franz Rischard, University of Arizona

The PVRI GoDeep Registry: Building the World's Largest Meta-Registry for Deep Phenotyping in PH
🎙 Athiththan Yogeswaran, Justus Liebig Universität Giessen

PVRI 2027 Bangkok
Bridging Science, Innovation & Care for the Next 20 Years
📅 27-31 January 2027
📍 Amari Bangkok Hotel & Conference Centre

🎟 Register now: https://t.co/2seRdteLsh

[The Pulmonary Vascular Research Institute @PVRI]

One week to go! 📢

Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise
📅 17 November 2026
🕐️ 13:00 GMT

From high-altitude expeditions to animal physiology, hypoxia can teach us a great deal about how the heart and lungs respond under stress.

➡️ Register now: https://t.co/mfdf0sreLE

[The Pulmonary Vascular Research Institute @PVRI]

#LivingUnderPressure: Empowering patients through knowledge 💜

Living with pulmonary hypertension (PH) can mean navigating uncertainty, complex medical information and difficult decisions about care. But patients should never feel under pressure to make decisions without the information and support they need.

Understanding clinical trials can help people living with PH feel informed, confident and empowered to take an active role in research and care.

PVRI's 'Understanding clinical trials' video series helps patients better understand clinical research and why their voices matter in shaping future research and treatment.
Explore the series here: https://t.co/oXRqz7j21y
OR watch here: https://t.co/cSWoUHOoXv

#PHAwarenessMonth #PulmonaryHypertension #PatientEmpowerment #ClinicalTrials

[The Pulmonary Vascular Research Institute @PVRI]

Generated important new data?
Late-breaking abstract submissions are now open 📢

PVRI 2027 Bangkok is now accepting late-breaking abstracts showcasing highly impactful findings. We are particularly interested in:

🔬 major clinical trials
📊 landmark registry analyses
🧬 transformative translational discoveries
💡 emerging technologies with immediate clinical relevance

Late-breaking submissions provide an opportunity to share the very latest advances with the global PH community and help shape discussions at PVRI 2027 Bangkok.

📅 Deadline: 30 November 2026, 09:00 GMT
➡️ Submit your abstract: https://t.co/d4X6nLQwCF

[The Pulmonary Vascular Research Institute @PVRI]

We're proud to support #PHDayUK 2026 💜

Raising awareness is an important step towards earlier diagnosis, better understanding and improved outcomes for people living with PH.

That's why we're backing this year's #WeNeedToTalkAboutPH campaign. Every conversation helps more people recognise the signs and symptoms of PH and understand the impact it can have on daily life.

Join us in supporting this year's campaign: https://t.co/lo8Ecuw5sA

[The Pulmonary Vascular Research Institute @PVRI]

✅ Is taking part in a clinical trial right for you?

There is no single right answer. Every person, situation, and clinical trial is different.

In this video from our 'Understanding clinical trials' PH patient collection, Huan Huang from PHA China explores some of the factors patients may wish to consider when making decisions about research participation.

🎥 Watch the full series: https://t.co/oXRqz7j21y

[The Pulmonary Vascular Research Institute @PVRI]

One week to go! ⏳️

Blood Biomarkers in PAH – New Insights
📅 12 November 2026
🕓️ 16:00 - 17:00 GMT

You'll hear talks on:

▪️Validation of biomarkers for clinical use: methological challenges and the path forward - Anna Hemnes, Vanderbilt University
▪️Use of the plasma proteosome for risk stratifying patients with PAH
Christopher J. Rhodes, National Heart and Lung Institute, Imperial College
▪️NOTCH3-ECD as a Biomarker for PAH - Patricia A. Thistlethwaite, University of California
▪️Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in PAH - Mona Alotaibi, University of California San Diego
▪️Blood endostatin, a Collagen18a1 fragment, as markers of vascular dysfunction in PAH - Grazyna Kwapiszewska, University of Graz

➡️ Register now: https://t.co/UJFgIVd6Gj

[The Pulmonary Vascular Research Institute @PVRI]

You may know the right clinician 💬

Global PH Consult gives clinicians the opportunity to bring anonymised complex PH cases to a tailored panel of PH specialists for discussion and shared learning.

Help us spread the word by sharing Global PH Consult with:

▪️colleagues managing complex PH cases
▪️regional PH centres
▪️clinical networks and professional societies
▪️clinicians working in low- and middle-income countries

A single recommendation could connect a clinician with valuable PH discussion, specialist perspectives, and a global learning community.

➡️ Find out more: https://t.co/A9unkmsXsS

[The Pulmonary Vascular Research Institute @PVRI]

Thank you to everyone who submitted an abstract for PVRI 2027 Bangkok 👏

We're delighted by the quality and diversity of submissions received from across the global PH community, showcasing the latest advances in research, clinical care, innovation and collaboration.

Congratulations to all authors whose abstracts have been accepted for presentation in Bangkok. We look forward to showcasing your work!

➡️ View the programme and register: https://t.co/2seRdteLsh

[The Pulmonary Vascular Research Institute @PVRI]

🫁 🌏 This #PHAwarenessMonth, we’re sharing a video from the PH Association highlighting the real-life experiences of people living with pulmonary hypertension - from symptoms and diagnosis to treatment and daily life. Their stories remind us that no one has to navigate this journey alone. https://t.co/pAkwfiSgIb

For anyone living with PH, explore PVRI's trusted resources to help you understand treatment options, navigate daily life, learn about clinical trials, and access emotional and peer support: https://t.co/oK5PLvVZYs
#PulmonaryHypertension #PHCommunity @PHAssociation

[Wiley Clinical and Health @WileyHealth]

As the official journal of @PVRI #PulmonaryCirculation journal features high-quality, peer-reviewed articles from leading experts in the field of pulmonary circulation, from pulmonary hypertension to lung transplantation #JournalSpotlight
Visit now: https://t.co/dgWEjvQ37T

[The Pulmonary Vascular Research Institute @PVRI]

In this state-of-the-art review, researchers from basic science, clinical research, and industry came together through the Pulmonary Vascular Research Institute (PVRI) Innovative Drug Discovery Initiative (IDDI) to discuss:

🔹 The biology of ASIs
🔹 The importance of specific BMP ligands
🔹 Efficacy and side effect profiles
🔹 Key considerations for developing next-generation ASIs

📖 Read the full review: https://t.co/Wu8WQcYqSi
#PulmonaryHypertension #DrugDiscovery #MedicalResearch

[The Pulmonary Vascular Research Institute @PVRI]

❓️Planning to join us in Bangkok?
Only one month left to secure the special PVRI delegate hotel rate ⏳️

Stay at the Amari Bangkok Hotel & Conference Centre, and be steps away from the main scientific programme.

By staying at the venue, you'll be just moments away from:
✅ scientific sessions and satellite meetings
✅ Congress luncheons and networking events
✅ fundraising activities
✅ Gala Dinner & Awards Presentation Evening

January is a busy time to visit Bangkok, so we recommend booking your room early.

➡️ Book your hotel: https://t.co/VqqlhjIYeJ
📅 Delegate rates available until 30 November 2026

[The Pulmonary Vascular Research Institute @PVRI]

New research in Pulmonary Circulation 🫁

Referral Patterns and Clinical Characteristics of Patients With Pulmonary Hypertension at a Comprehensive Care Center
📆 10 September 2026
🔢 16(3), e70399
👤 Nelson Villasmil Hernandez, Maria Jose Maestre, Meagan Chavarria, Pujita Munnangi, Neelam Lakhani, Laura Valecillos Loukidis, Sandeep Sahay

➡️ Read the full research article: https://t.co/cTipSl0rDU

[The Pulmonary Vascular Research Institute @PVRI]

🌏 We’re delighted to share that the PVRI Southeast Asia Task Force was relaunched in September 2026

The Task Force, co-led by Dr Suree Sompradeekul (Thailand) and Dr Ruan Wen (Singapore), aims to:

🔹 Strengthen collaboration and knowledge-sharing across Southeast Asia’s PH community
🔹 Identify regional priorities to improve PH diagnosis, treatment, and patient outcomes
🔹 Advance regional and national guidelines, registries, and data-sharing
🔹 Build a lasting regional network beyond PVRI 2027 in Bangkok

Learn more about the Task Force’s relaunch, activities, and future plans: https://t.co/0R3RNcZIYl
#PulmonaryHypertension #PH #SoutheastAsia

[The Pulmonary Vascular Research Institute @PVRI]

Missed our October Community Call?

Our latest Community Call is now available on demand! Featuring Tyler Couch, Agustin Garcia and Olympia Bikou, the session explored the following:

🔹 Pulmonary artery dilation on chest CT Across the spectrum of chronic lung disease
🔹 CT imaging derived pulmonary vascular abnormalities associated with PH in chronic lung disease
🔹 MicroRNA-224 as a therapeutic target in preclinical pulmonary arterial hypertension

▶️ Watch the session now: https://t.co/amQuFxyE1i
#PulmonaryHypertension #PHResearch